Total pharmaceutical sales in Norway were recorded at 3.86 billion USD in 2023. From 2024 onward, sales are forecasted to increase steadily from 3.95 billion USD to 4.3 billion USD by 2028, representing a consistent year-on-year growth ranging from 2.28% to 2.14%. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is approximately 2.26%.
Future trends to watch for include increased investment in biopharmaceuticals, potential impact of policy changes on drug pricing, digital health innovations, and an aging population that may drive more demand for pharmaceuticals. Continued focus on precision medicine and personalized healthcare solutions could also significantly influence market growth.
